Long-term treatment with the pan-PPAR agonist tetradecylthioacetic acid or fish oil is associated with increased cardiac content of n-3 fatty acids in rat

Lipids in Health and Disease

Volumn 11, Issue , 2012, Pages

  Strand, Elin ^a   Bjorndal, Bodil ^a   Nygard, Ottar ^a,b   Burri, Lena ^a   Berge, Christ ^b   Bohov, Pavol ^a   Christensen, Bjørn J ^a,b   Berge, Kjetil ^a   Wergedahl, Hege ^c   Viste, Asgaut ^a,b   Berge, Rolf K ^a,b  

^a UNIVERSITY OF BERGEN   (Norway)

^b HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^c BERGEN UNIVERSITY COLLEGE   (Norway)

Author keywords

Heart metabolism; Peroxisome proliferator activated receptor; Polyunsaturated fatty acids; Tetradecylthioacetic acid

Indexed keywords

ACYL COENZYME A OXIDASE; ARACHIDONIC ACID; CARNITINE PALMITOYLTRANSFERASE; CARNITINE PALMITOYLTRANSFERASE II; FATTY ACID SYNTHASE; FATTY ACID TRANSPORTER; FATTY ACID TRANSPORTER 1; FISH OIL; GLYCEROL 3 PHOSPHATE ACYLTRANSFERASE; MESSENGER RNA; OMEGA 3 FATTY ACID; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR AGONIST; TETRADECYLTHIOACETIC ACID; UNCLASSIFIED DRUG; UNCOUPLING PROTEIN 3;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG MEGADOSE; ENZYME ACTIVITY; GENE EXPRESSION; HEART; LIPID COMPOSITION; LIPID DIET; LIPID LIVER LEVEL; LIPID METABOLISM; LONG TERM CARE; MALE; NONHUMAN; PILOT STUDY; RAT; UPREGULATION;

ACYL-COA OXIDASE; ANIMALS; CARNITINE O-PALMITOYLTRANSFERASE; FATTY ACIDS, OMEGA-3; FISH OILS; GENE EXPRESSION; GLYCEROL-3-PHOSPHATE O-ACYLTRANSFERASE; ION CHANNELS; LIPID METABOLISM; LIVER; MALE; MITOCHONDRIAL PROTEINS; MYOCARDIUM; ORGAN SPECIFICITY; PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS; RATS; RATS, WISTAR; SULFIDES; TIME FACTORS;

RATTUS; RATTUS NORVEGICUS;

EID: 84862728904     PISSN: None     EISSN: 1476511X     Source Type: Journal    
DOI: 10.1186/1476-511X-11-82     Document Type: Article

References (58)

1. The PPAR trio: Regulators of myocardial energy metabolism in health and disease. Madrazo JA, Kelly DP, J Mol Cell Cardiol 2008 44 968 975 10.1016/j.yjmcc.2008.03.021 18462747
2. The failing heart-an engine out of fuel. Neubauer S, N Engl J Med 2007 356 1140 1151 10.1056/NEJMra063052 17360992
3. Effectors of fatty acid oxidation reduction: promising new anti-ischaemic agents. Grynberg A, Curr Pharm Des 2005 11 489 509 10.2174/1381612053382061 15725067
4. Myocardial substrate metabolism in the normal and failing heart. Stanley WC, Recchia FA, Lopaschuk GD, Physiol Rev 2005 85 1093 1129 10.1152/physrev. 00006.2004 15987803
5. Chronic activation of PPARalpha is detrimental to cardiac recovery after ischemia. Sambandam N, Morabito D, Wagg C, Finck BN, Kelly DP, Lopaschuk GD, Am J Physiol Heart Circ Physiol 2006 290 87 95 16155108
6. Upregulation of fatty acyl-CoA thioesterases in the heart and skeletal muscle of rats fed a high-fat diet. Fujita M, Momose A, Ohtomo T, Nishinosono A, Tanonaka K, Toyoda H, Morikawa M, Yamada J, Biol Pharm Bull 2011 34 87 91 10.1248/bpb.34.87 21212523
7. Mechanisms for increased myocardial fatty acid utilization following short-term high-fat feeding. Wright JJ, Kim J, Buchanan J, Boudina S, Sena S, Bakirtzi K, Ilkun O, Theobald HA, Cooksey RC, Kandror KV, Abel ED, Cardiovasc Res 2009 82 351 360 19147655
8. The cardiac phenotype induced by PPARalpha overexpression mimics that caused by diabetes mellitus. Finck BN, Lehman JJ, Leone TC, Welch MJ, Bennett MJ, Kovacs A, Han X, Gross RW, Kozak R, Lopaschuk GD, Kelly DP, J Clin Invest 2002 109 121 130 11781357
9. Mitochondrial protein phosphorylation: instigator or target of lipotoxicity? Graier WF, Malli R, Kostner GM, Trends Endocrinol Metab 2009 20 186 193 10.1016/j.tem.2009.01.004 19356948
10. Omega-3 fatty acids and coronary heart disease risk: clinical and mechanistic perspectives. Harris WS, Miller M, Tighe AP, Davidson MH, Schaefer EJ, Atherosclerosis 2008 197 12 24 10.1016/j.atherosclerosis.2007.11.008 18160071
11. Dose-dependent effects of omega-3-polyunsaturated fatty acids on systolic left ventricular function, endothelial function, and markers of inflammation in chronic heart failure of nonischemic origin: a double-blind, placebo-controlled, 3-arm study. Moertl D, Hammer A, Steiner S, Hutuleac R, Vonbank K, Berger R, Am Heart J 2011 161 915 e911 919
12. Dietary intake of n-3 long-chain polyunsaturated fatty acids and coronary events in Norwegian patients with coronary artery disease. Manger MS, Strand E, Ebbing M, Seifert R, Refsum H, Nordrehaug JE, Nilsen DW, Drevon CA, Tell GS, Bleie O, et al. Am J Clin Nutr 2010 92 244 251 10.3945/ajcn.2010.29175 20484456
13. Cardiovascular effects of marine omega-3 fatty acids. Saravanan P, Davidson NC, Schmidt EB, Calder PC, Lancet 2010 376 540 550 10.1016/S0140- 6736(10)60445-X 20638121
14. Dei Cas L: Effects of n-3 polyunsaturated fatty acids on left ventricular function and functional capacity in patients with dilated cardiomyopathy. Nodari S, Triggiani M, Campia U, Manerba A, Milesi G, Cesana BM, Gheorghiade M, J Am Coll Cardiol 2011 57 870 879 10.1016/j.jacc.2010.11.017 21215550
15. Vanden Heuvel JP, Wagner PR, West SG: Dose-response effects of omega-3 fatty acids on triglycerides, inflammation, and endothelial function in healthy persons with moderate hypertriglyceridemia. Skulas-Ray AC, Kris-Etherton PM, Harris WS, Am J Clin Nutr 2011 93 243 252 10.3945/ajcn.110.003871 21159789
16. Use of fibrates in the United States and Canada. Jackevicius CA, Tu JV, Ross JS, Ko DT, Carreon D, Krumholz HM, JAMA 2011 305 1217 1224 10.1001/jama.2011.353 21427374
17. Hyperlipidaemia and cardiovascular disease: do fibrates have a role? Saha SA, Arora RR, Curr Opin Lipidol 2011 22 270 276 10.1097/MOL.0b013e32834701c3 21519250
18. Fibrates in the treatment of dyslipidemias-time for a reassessment. Goldfine AB, Kaul S, Hiatt WR, N Engl J Med 2011 365 481 484 10.1056/NEJMp1106688 21830963
19. Modulation of keratinocyte gene expression and differentiation by PPAR-selective ligands and tetradecylthioacetic acid. Westergaard M, Henningsen J, Svendsen ML, Johansen C, Jensen UB, Schroder HD, Kratchmarova I, Berge RK, Iversen L, Bolund L, et al. J Invest Dermatol 2001 116 702 712 10.1046/j.1523-1747.2001.01329.x 11348458
20. Dietary supplementation of tetradecylthioacetic acid increases feed intake but reduces body weight gain and adipose depot sizes in rats fed on high-fat diets. Wensaas AJ, Rustan AC, Rokling-Andersen MH, Caesar R, Jensen J, Kaalhus O, Graff BA, Gudbrandsen OA, Berge RK, Drevon CA, Diabetes Obes Metab 2009 11 1034 1049 10.1111/j.1463-1326.2009.01092.x 19740081
21. Antiinflammatory effects of tetradecylthioacetic acid involve both peroxisome proliferator-activated receptor alpha-dependent and -independent pathways. Dyroy E, Yndestad A, Ueland T, Halvorsen B, Damas JK, Aukrust P, Berge RK, Arterioscler Thromb Vasc Biol 2005 25 1364 1369 10.1161/01.ATV.0000171982. 57713.96 15920037
22. Cardiac peroxisome proliferator-activated receptor-alpha activation causes increased fatty acid oxidation, reducing efficiency and post-ischaemic functional loss. Hafstad AD, Khalid AM, Hagve M, Lund T, Larsen TS, Severson DL, Clarke K, Berge RK, Aasum E, Cardiovasc Res 2009 83 519 526 10.1093/cvr/cvp132 19398469
23. Enhancement of long-chain acyl-CoA hydrolase activity in peroxisomes and mitochondria of rat liver by peroxisomal proliferators. Berge RK, Flatmark T, Osmundsen H, Eur J Biochem 1984 141 637 644 10.1111/j.1432-1033.1984.tb08239.x 6146524
24. Docosahexaenoic and eicosapentaenoic acids are differently metabolized in rat liver during mitochondria and peroxisome proliferation. Madsen L, Froyland L, Dyroy E, Helland K, Berge RK, J Lipid Res 1998 39 583 593 9548590
25. Fish protein hydrolysate reduces plasma total cholesterol, increases the proportion of HDL cholesterol, and lowers acyl-CoA:cholesterol acyltransferase activity in liver of Zucker rats. Wergedahl H, Liaset B, Gudbrandsen OA, Lied E, Espe M, Muna Z, Mork S, Berge RK, J Nutr 2004 134 1320 1327 15173391
26. Peroxisome proliferator-activated receptor alpha agonist, clofibrate, has profound influence on myocardial fatty acid composition. Tian Q, Grzemski FA, Panagiotopoulos S, Ahokas JT, Chemico-biological interactions 2006 160 241 251 10.1016/j.cbi.2006.02.003 16540100
27. Cardioprotective effect of the PPAR ligand tetradecylthioacetic acid in type 2 diabetic mice. Khalid AM, Hafstad AD, Larsen TS, Severson DL, Boardman N, Hagve M, Berge RK, Aasum E, Am J Physiol Heart Circ Physiol 2011 300 2116 2122 10.1152/ajpheart.00357.2010 21421822
28. Fish oil and 3-thia fatty acid have additive effects on lipid metabolism but antagonistic effects on oxidative damage when fed to rats for 50 weeks. Vigerust NF, Cacabelos D, Burri L, Berge K, Wergedahl H, Christensen B, Portero-Otin M, Viste A, Pamplona R, Berge RK, Bjorndal B, J Nutr Biochem 2012
29. Changed energy state and increased mitochondrial beta-oxidation rate in liver of rats associated with lowered proton electrochemical potential and stimulated uncoupling protein 2 (UCP-2) expression: evidence for peroxisome proliferator-activated receptor-alpha independent induction of UCP-2 expression. Grav HJ, Tronstad KJ, Gudbrandsen OA, Berge K, Fladmark KE, Martinsen TC, Waldum H, Wergedahl H, Berge RK, J Biol Chem 2003 278 30525 30533 10.1074/jbc.M303382200 12756242
30. Inhibition of rat lipoprotein oxidation after tetradecylthioacetic acid feeding. Muna ZA, Gudbrandsen OA, Wergedahl H, Bohov P, Skorve J, Berge RK, Biochem Pharmacol 2002 63 1127 1135 10.1016/S0006-2952(01)00934-0 11931845
31. Dietary omega-3 fatty acids alter cardiac mitochondrial phospholipid composition and delay Ca2+induced permeability transition. O'Shea KM, Khairallah RJ, Sparagna GC, Xu W, Hecker PA, Robillard-Frayne I, Des Rosiers C, Kristian T, Murphy RC, Fiskum G, Stanley WC, J Mol Cell Cardiol 2009 47 819 827 10.1016/j.yjmcc.2009.08.014 19703463
32. Docosapentaenoic acid (22:5n-3): a review of its biological effects. Kaur G, Cameron-Smith D, Garg M, Sinclair AJ, Progress in lipid research 2011 50 28 34 10.1016/j.plipres.2010.07.004 20655949
33. Modulation of rat liver apolipoprotein gene expression and serum lipid levels by tetradecylthioacetic acid (TTA) via PPARalpha activation. Raspe E, Madsen L, Lefebvre AM, Leitersdorf I, Gelman L, Peinado-Onsurbe J, Dallongeville J, Fruchart JC, Berge R, Staels B, Journal of lipid research 1999 40 2099 2110 10553013
34. Glycerol-3-phosphate acyltransferases: rate limiting enzymes of triacylglycerol biosynthesis. Wendel AA, Lewin TM, Coleman RA, Biochim Biophys Acta 2009 1791 501 506 10.1016/j.bbalip.2008.10.010 19038363
35. In contrast with docosahexaenoic acid, eicosapentaenoic acid and hypolipidaemic derivatives decrease hepatic synthesis and secretion of triacylglycerol by decreased diacylglycerol acyltransferase activity and stimulation of fatty acid oxidation. Berge RK, Madsen L, Vaagenes H, Tronstad KJ, Gottlicher M, Rustan AC, Biochem J 1999 343 Pt 1 191 197 10493929
36. 3-Thia fatty acid treatment, in contrast to eicosapentaenoic acid and starvation, induces gene expression of carnitine palmitoyltransferase-II in rat liver. Madsen L, Berge RK, Lipids 1999 34 447 456 10.1007/s11745-999-0384-6 10380116
37. Carnitine palmitoyl transferase I and the control of beta-oxidation in heart mitochondria. Eaton S, Bartlett K, Quant PA, Biochem Biophys Res Commun 2001 285 537 539 10.1006/bbrc.2001.5201 11444876
38. Monitoring energy balance: metabolites of fatty acid synthesis as hypothalamic sensors. Dowell P, Hu Z, Lane MD, Annu Rev Biochem 2005 74 515 534 10.1146/annurev.biochem.73.011303.074027 15952896
39. The regulation and turnover of mitochondrial uncoupling proteins. Azzu V, Jastroch M, Divakaruni AS, Brand MD, Biochim Biophys Acta 1797 785 791
40. A high fat diet increases mitochondrial fatty acid oxidation and uncoupling to decrease efficiency in rat heart. Cole MA, Murray AJ, Cochlin LE, Heather LC, McAleese S, Knight NS, Sutton E, Jamil AA, Parassol N, Clarke K, Basic research in cardiology 2011 106 447 457 10.1007/s00395-011-0156-1 21318295
41. The essentiality of arachidonic acid and docosahexaenoic acid. Le HD, Meisel JA, de Meijer VE, Gura KM, Puder M, Prostaglandins Leukot Essent Fatty Acids 2009 81 165 170 10.1016/j.plefa.2009.05.020 19540099
42. Effects of essential fatty acid deficiency on mitochondria and peroxisomes in rat hepatocytes with special reference to a partially hydrogenated fish oil diet. Kryvi H, Christiansen E, Tangeras A, Flatmark T, Biochim Biophys Acta 1986 881 87 92 10.1016/0304-4165(86)90100-5 3947675
43. Fenofibrate simultaneously induces hepatic fatty acid oxidation, synthesis, and elongation in mice. Oosterveer MH, Grefhorst A, van Dijk TH, Havinga R, Staels B, Kuipers F, Groen AK, Reijngoud DJ, J Biol Chem 2009 284 34036 34044 10.1074/jbc.M109.051052 19801551
44. N-3 PUFA supplementation triggers PPAR-alpha activation and PPAR-alpha/NF-kappaB interaction: anti-inflammatory implications in liver ischemia-reperfusion injury. Zuniga J, Cancino M, Medina F, Varela P, Vargas R, Tapia G, Videla LA, Fernandez V, PLoS One 2011 6 28502 10.1371/journal.pone. 0028502 22174823
45. Beyond lipids, pharmacological PPARalpha activation has important effects on amino acid metabolism as studied in the rat. Sheikh K, Camejo G, Lanne B, Halvarsson T, Landergren MR, Oakes ND, Am J Physiol Endocrinol Metab 2007 292 1157 1165 17164430
46. Induction of peroxisomal beta-oxidation in 7800C1 Morris hepatoma cells in steady state by fatty acids and fatty acid analogues. Spydevold O, Bremer J, Biochim Biophys Acta 1989 1003 72 79 10.1016/0005-2760(89)90101-X 2713397
47. Bioactive Fatty Acids Reduce Development of Gastric Cancer Following Duodenogastric Reflux in Rats. Christensen BJ, Berge K, Wergedahl H, Bohov P, Berge RK, Svendsen E, Viste A, Surg Sci 2012 3 34 42 10.4236/ss.2012.31006
48. A rapid method of total lipid extraction and purification. Bligh EG, Dyer WJ, Can J Biochem Physiol 1959 37 911 917 10.1139/o59-099 13671378
49. General analytical procedures. Kates M, Techniques of Lipidology Elsevier Science Publishers, Amsterdam MD, 1986 112 185
50. Decreased production of interleukin-1-beta, prostaglandin-E2 and thromboxane-B2, and elevated levels of interleukin-6 and -10 are associated with increased survival during endotoxic shock in mice consuming diets enriched with sesame seed oil supplemented with Quil-A saponin. Chavali SR, Zhong WW, Utsunomiya T, Forse RA, Int Arch Allergy Immunol 1997 114 153 160 10.1159/000237661 9338609
51. Effect of a high-fat diet with partially hydrogenated fish oil on long-chain fatty acid metabolizing enzymes in subcellular fractions of rat liver. Berge RK, Flatmark T, Christiansen EN, Arch Biochem Biophys 1987 252 269 276 10.1016/0003-9861(87)90031-2 2880562
52. Rapid stimulation of liver palmitoyl-CoA synthetase, carnitine palmitoyltransferase and glycerophosphate acyltransferase compared to peroxisomal beta-oxidation and palmitoyl-CoA hydrolase in rats fed high-fat diets. Berge RK, Nilsson A, Husoy AM, Biochim Biophys Acta 1988 960 417 426 10.1016/0005-2760(88)90050-1 2898261
53. A selective decrease in mitochondrial glycerol phosphate acyltransferase activity in livers from streptozotocin-diabetic rats. Bates EJ, Saggerson D, FEBS Lett 1977 84 229 232 10.1016/0014-5793(77)80694-7 598502
54. On the mechanism of the hypolipidemic effect of sulfur-substituted hexadecanedioic acid (3-thiadicarboxylic acid) in normolipidemic rats. Skorve J, al-Shurbaji A, Asiedu D, Bjorkhem I, Berglund L, Berge RK, J Lipid Res 1993 34 1177 1185 8371065
55. The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments. Bustin SA, Benes V, Garson JA, Hellemans J, Huggett J, Kubista M, Mueller R, Nolan T, Pfaffl MW, Shipley GL, et al. Clin Chem 2009 55 611 622 10.1373/clinchem.2008.112797 19246619
56. Quantification of mRNA using real-time RT-PCR. Nolan T, Hands RE, Bustin SA, Nat Protoc 2006 1 1559 1582 10.1038/nprot.2006.236 17406449
57. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Vandesompele J, De Preter K, Pattyn F, Poppe B, Van Roy N, De Paepe A, Speleman F, Genome Biol 2002 3 ESEARCH0034 12184808
58. The statistics of synergism. Slinker BK, J Mol Cell Cardiol 1998 30 723 731 10.1006/jmcc.1998.0655 9602421